<DOC>
	<DOCNO>NCT00727493</DOCNO>
	<brief_summary>The purpose study evaluate influence alendronate therapy wound heal dental implant patient osteoporosis .</brief_summary>
	<brief_title>Osteoporosis Dental Implant</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Postmenopausal woman &gt; 2 year menopause Age 60 75 year Possibility insert dental implant Osteoporosis define WHO criteria ( intervention group ) , woman without osteoporosis / osteopenia ( nonintervention group ) Pathological finding jaw bone Chronic inflammatory rheumatoid disease Bisphosphonate treatment last 12 month Inflammatory metabolic bone disease , exclude osteoporosis Systemic corticosteroid treatment one month within previous 12 month Severe diseases life expectancy le one year expectation rapid worsen within one year</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>osteoporosis ,</keyword>
	<keyword>bisphosphonate</keyword>
	<keyword>therapy</keyword>
	<keyword>dental implant</keyword>
</DOC>